Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acoustic neurinoma
acute disseminated encephalomyelitis
acute necrotizing encephalitis
advances in neurology
adverse drug reaction
alcohol
alemtuzumab
algorithm
altered states of consciousness
Alzheimer's disease
Alzheimer's disease, preclinical
amphetamines
amyloid angiopathy, cerebral
amyloid beta protein
amyloid imaging
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
angiitis, isolated of CNS, benign focal
angiography, cerebral, beaded vessels
angiography, cerebral
angiography, cerebral, reversible abnormality
anti MAG antibodies
antiviral agents
aphasia
apolipoprotein E
Arnold Chiari malformation
arteriopathy
asterixis
asymptomatic
autoantibodies
autoimmune disease
B 12 deficiency
basilar impression
behavioral disorder
Behcet's syndrome
benign essential tremor
benign positional vertigo
beta adrenergic blocker
biologic markers
brain atrophy
brain biopsy
brain scan
brain volume
brainstem, infarction of
calcification, intracranial
calcium antagonist
Call-Fleming syndrome
carbon monoxide poisoning
carcinoma
carcinoma of lung
cardiovascular disease
carotid artery occlusion, neck
carotid artery stenosis
case studies
CAT scan
CAT scan, abnormal
CAT scan, demyelinating disease
cataracts, congenital
central nervous system, infection of
central pontine myelinolysis
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral edema
cerebral edema, vasogenic
cerebral infarction, hemorrhagic
cerebral palsy
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, cytology
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, xanthochromia of
cerebrovascular accident
cerebrovascular accident, non atherosclerotic cause of
cerebrovascular accident, women
cerebrovascular accident, young adult
cerebrovascular disease, risk factors in
chemotherapy, CNS treatment and complications with
chorioretinitis
cognition
coma
complications
concentric sclerosis
congenital malformation
conus medullaris, lesion of
conversion reaction
cortical blindness
cranio-cervical junction
cyst, benign intracranial
cyst, cortical parenchyma
cyst, porencephalic
cytomegalic inclusion disease
cytosine arabinoside
daclizumab
delirium
dementia
dementia, early detection
demyelinating disease
depression
depression, psychotic
dermatomyositis
diagnostic criteria
differential diagnosis
dilantin
diplopia
disability rating scale, neurological
disability, neurological
down-beat nystagmus
drowsiness
drug induced neurologic disorders
dysarthria
dysexecutive syndrome
dystonia
educational status
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electron microscopy
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, human immunodeficiency virus type 1
encephalitis, viral
encephalomalacia
encephalomyelitis, postinfectious
epidemiology of neurology
eye movement, disorders of
eye, pain in
facial nerve palsy
facial pain
familial
fever
florbetapir
foramen magnum, meningioma
gadolinium
gamma knife therapy
gaze palsy
gaze palsy, horizontal
gender
glioblastoma multiforme(astrocytoma Gr.III)
glioma
gliomatosis cerebri
groin pain
Guillain Barre syndrome
hallucination, auditory
hallucination, hypnagogic
head injury
head injury, severe
head nodding
headache
headache, recurrent
headache, severe
headache, thunderclap
hearing loss
heavy metal intoxication
hemiparesis
hemiplegia
herniated disc
herniated disc, thoracic
herpes labialis
herpes simplex encephalitis
herpes simplex encephalitis, differential diagnosis of
herpes simplex encephalitis, recurrent
herpes simplex encephalitis, treatment of
herpes simplex myelitis
herpes simplex virus
herpes simplex virus infection, immunosuppressed patient
herpes simplex virus, human nervous system and
herpes simplex virus, localization of
herpes simplex virus, malignancy with
herpes simplex virus, pathogenesis of
herpes simplex virus, pathology of
herpes simplex, neurocutaneous lesions in
herpes virus
herpes zoster
herpes, genital
hiccoughs
hippocampal atrophy
hippocampus
holoprosencephaly
human immunodeficiency virus type 1
hydrocephalus
hypertension
hypertensive encephalopathy
hyperthyroidism
hypoglycemia
hypoglycorrhachia
hyponatremia
iatrogenic neurologic disorders
immunofluorescent exam of CSF cells
immunomodulation
immunosuppression
immunosuppressive agents
inclusion bodies, intranuclear
infectious mononucleosis
infliximab
interferon
interferon inducer
internuclear ophthalmoplegia
internuclear ophthalmoplegia, bilateral
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracranial hypertension, benign
intracranial pressure, increased
intrauterine infection, viral
intrauterine infection, viral of CNS
iododeoxyuridine
lacunar infarction
laughing, pathologic
leukoencephalopathy
leukoencephalopathy, differential diagnosis
level of consciousness, decreased
life expectancy
limbic encephalitis
limbic system
lobar atrophy
low back pain
low birth weight
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
malformation, CNS, congenital
memory, impairment of
meningitis
meningitis, aseptic
mental retardation
mental status, abnormal
microcephaly
micropthalmia
middle cerebral artery, occlusion of
middle cerebral artery, stenosis of
migraine
mild cognitive impairment
mimics
misdiagnosis
mitochondrial disease
monoamines
monoamines, brain
monoclonal antibodies
monoparesis
mortality
movement disorder
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, angiography
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, contrast enhanced, delayed
MRI, contrast enhanced, high dose
MRI, demyelinating disease
MRI, disappearing lesion on
MRI, false negative
MRI, field strength, high
MRI, negative
MRI, serial
MRI, volumetry
multiple sclerosis
multiple sclerosis, asymptomatic
multiple sclerosis, benign form of
multiple sclerosis, chronic progressive
multiple sclerosis, diagnosis of
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, misdiagnosis
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, tumefactive
myasthenia gravis
myelitis
myelitis, transverse
myelogram
myoclonus
mysoline
myxedema, neurologic manifestations of
narcolepsy
natalizumab
nausea and vomiting
neoplasm, intracranial, differential diagnosis of
neoplasm, metastatic to CNS
neoplasm, primary intracerebral
neoplasm, primary of CNS
neurologic disease
neurologic disease, diagnoses of
neurologic examination, focal
neurologic signs
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuromyelitis optica, IgG
neuroophthalmology
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, peripheral, treatment
nystagmus
nystagmus, central
nystagmus, peripheral
ocular bobbing
ocular dysmetria
old age, neurology of
optic atrophy
optic nerve, hypoplasia of
optic neuritis
optic neuritis, bilateral
pain
pain, abdominal
pain, back
papilledema
paraparesis
paraplegia
Parkinson disease
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
periventricular leukomalacia
personality change
personality disorder
phenylketonuria
Pittsburgh Compound B
pleocytosis of cerebrospinal fluid
poison, neurologic problems with
polyinosinic cytidic acid(poly IC)
polymyositis
polyneuropathy, chronic inflammatory demyelinating
pons, infarction of
posterior leukoencephalopathy syndrome
postpartum
potassium channel antibodies
precipitating factors
pregnancy, neurologic complications in
premature infant
prognosis
progressive multifocal leucoencephalopathy
propranolol
pseudotumor
psychiatric disorder
psychiatric problems in neurologic disorders
psychomotor retardation
psychosis
ptosis
pure motor stroke
race
radiation therapy, CNS treatment and complications with
radiation therapy, stereotactic
REM sleep
remote effect of cancer on the nervous system
reversible cerebral vasoconstrictive syndromes
reversible neurologic disorder
review article
risk factors
rituximab
rubella virus
safety
sarcoidosis
sarcoidosis, CNS
schizophrenia
seizure
seizure, neonatal
seizure, psychomotor-temporal lobe
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
skew deviation
sleep
sleep pathology and physiology
spinal cord, compression of
spinal cord, extramedullary cyst of
steroid therapy, CNS treatment and complications with
stimulation, deep brain
subacute myelo-opticoneuropathy(S.M.O.N.)complex
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
subtemporal decompression
symmetric brain lesions
syringomyelia
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
talk
tau protein
temporal lobe, lesion
temporal lobe, lesion, bilateral
thalamotomy
thromboangiitis obliterans cerebri
thyrotoxicosis
transplacental virus infections
treatment of neurologic disorder
tremor
tremor, cerebellar
tremor, classification
tremor, differential diagnosis of
tremor, intention
tremor, jaw
tremor, leg
tremor, rubral
tremor, surgical treatment of
tremor, thalamic stimulation for suppression of
tremor, treatment of
trigeminal neuralgia
twins
vaccination, neurologic complications with
vasculitides
vasculopathy
vasoconstrictive drugs
vasospasm
vasospasm, cerebral
vertebral-basilar insufficiency
vertebral-basilar insufficiency, differential diagnosis
vertigo
vertigo, basilar artery insufficiency
vertigo, central
vertigo, migraine causing
vertigo, ocular
vertigo, peripheral
vertigo, post-traumatic
viral infection, CNS
vision loss, sequential
visual loss
visual loss, progressive
visual loss, sudden
water channel antibodies
Whipple's disease
white matter disease
Showing articles 700 to 750 of 4864 << Previous Next >>

New T2 Lesions Enable an Earlier Diagnosis of Multiple Sclerosis in Clinically Isolated Syndromes
Ann Neurol 53:673-676, Dalton,C.M.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Three Subsequent Single Doses of Gadolinum Chelate for Brain MR Imaging in Multiple Sclerosis
AJNR 24:658-662, Sardanelli,F.,et al, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Asymmetric Flaccid Paralysis: A Neuromuscular Presentation of West Nile Virus Infection
Ann Neurol 53:703-710,691, Li,J.,et al, 2003

Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003

A Randomized Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS
Neurol 60:1955-1960, NASA/MS Cooling Study Group, 2003

The Outcome of Neurology Outpatients with Medically Unexplained Symptoms: A Prospective Cohort Study
JNNP 74:897-900,842, Carson,A.J.,et al, 2003

High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003

A Longitudinal Study of Brain Volume Changes in Normal Aging Using Serial Registered Magnetic Resonance Imaging
Arch Neurol 60:989-994, Scahill,R.I.,et al, 2003

Pain in Patients with Multiple Sclerosis
Arch Neurol 60:1089-1094, Svendsen,K.B.,et al, 2003

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

T2 Hypointensity in the Deep Gray Matter of Patients With Multiple Sclerosis
Arch Neurol 59:62-68, Bakshi,R.,et al, 2002

Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002

Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002

Course and Prognosis in Early-Onset MS
Neurol 59:1922-1928, Simone,I.L., etla, 2002

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002

Management of Acute Optic Neuritis
Lancet 360:1953-1962, Hickman,S.J.,et al, 2002

Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002

Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002

Cause and Prognosis of Nontraumatic Sixth Nerve Palsies in Young Adults
Ophthalmology 109:1925-1928, Peters III,G.B.,et al, 2002

Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002

Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002

Sandlike Appearance of Virchow-Robin Spaces in Early Multiple Sclerosis:A Novel Neuroradiologic Marker
AJNR 23:376-380, Achiron,A.&Faibel,M., 2002

Recent Developments in Neurology
BMJ 324:656-660, Wiebe,S.,&Nicolle,M.W., 2002

Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002

Multiple Sclerosis
Lancet 359:1221-1231, Compston,A. &Coles,A., 2002

Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS
Neurol 58:1404-1407,1323, Killestein,J.,et al, 2002

Patients with Multiple Sclerosis and Risk of Type 1 Diabetes Mellitus in Sardinia,Italy: A Cohort Study
Lancet 359:1461-1465,1450, Marrosu,M.G.,et al, 2002

Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002

Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
Radiology 223:46-56, Bot,J.C.J.,et al, 2002

Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002

Acquired Sexual Parphilia in Patients with Multiple Sclerosis
Arch Neurol 59:1006-1010, Frohman,E.M.,et al, 2002

Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002

Bacterial Infection as a Cause of Multiple Sclerosis
Lancet 360:352-353, Wolfson,C. &Talbot,P., 2002

Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator
Stroke 33:2047-2052, Selim,M.,et al, 2002

Nonmotor Fluctuations in Parkinson's Disease
Neurol 59:408-413, Witjas,T.,et al, 2002

Progressive Ventricular Enlargement in Patients with Clinically Isolated Syndromes is Associated with the Early Development of Multiple Sclerosis
JNNP 73:141-147, Dalton,C.M.,et al, 2002

Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002

Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Is a "Vanishing Tumor" Always a Lymphoma?
Neurol 59:762-764, Bromberg,J.E.C.,et al, 2002

Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002

Acute Disseminated Encephalomyelitis
Neurol 59:1224-1231, Tenembaum,S.,et al, 2002

Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002

MRI Predictors of Early Conversion to Clinically Definite MS in the CHAMPS Placebo Group
Neurol 59:998-1005, CHAMPS Study Group, 2002

Proton MR Spectroscopy of Tumefactive Demyelinating Lesions
AJNR 23:1378-1386, Saindane,A.M.,et al, 2002



Showing articles 700 to 750 of 4864 << Previous Next >>